INS and metabolic dysfunction-associated steatotic liver disease: Specifically, this may be due to the fact that pancreatic beta cells are the only cells that produce insulin, but in individuals with higher BMI, beta-cell function is impaired and pancreatic volume is reduced, thereby promoting the development of type 2 diabetes and further increasing the risk of NAFLD incidence (51–53).